|
advertisement
|
|
|
| Journal Articles Details
|
| Pharmacogenomics Journals |
| Pharmacogenomics J. 4(6):354-8 |
Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs. |
Zineh I, Gerhard T, Aquilante CL, Beitelshees AL, Beasley BN, Hartzema AG.
[1] 1Department of Pharmacy Practice, University of Florida College of Pharmacy, Gainesville, FL, USA [2] 2University of Florida Center for Pharmacogenomics, Gainesville, FL, USA. |
Publication Date: Friday, November 19, 2004
|
Click here to view MEDLINE citation |
|
More November, 2004 pharmacogenomics journal articles.- Pharmacogenetics and cardiovascular disease management.
by Weston CF.
Journal: Hosp Med. 65(10):594-8
- Medication errors in pediatrics-the octopus evading defeat.
by Sullivan JE, Buchino JJ.
Journal: J Surg Oncol. November 2004;88(3):182-188
- Pharmacogenetics of acute lymphoblastic leukemia.
by Mehta PA, Davies SM.
Journal: Curr Opin Hematol. 11(6):434-438
- Pharmacogenetics of nicotine metabolism in twins: methods and procedures.
by Swan GE, Benowitz NL, Jacob P, Lessov CN, Tyndale RF, Wilhelmsen K, Krasnow RE, McElroy MR, Moore SE, Wambach M.
Journal: Twin Res. 7(5):435-48
- Gene expression microarray technologies in the development of new therapeutic agents.
by Clarke PA, te Poele R, Workman P.
Journal: Eur J Cancer. 40(17):2560-91
- Pharmacogenomics in admixed populations: the Brazilian pharmacogenetics/pharmacogenomics network-REFARGEN.
by Suarez-Kurtz G.
Journal: Pharmacogenomics J. 4(6):347-8
- In genetic control of disease, does 'race' matter?
by Goldstein DB, Hirschhorn JN.
Journal: Nat Genet. 36(12):1243-1244
- Identification of single-nucleotide polymorphisms of the human neurokinin 1 receptor gene and pharmacological characterization of a Y192H variant.
by Randolph GP, Simon JS, Arreaza MG, Qiu P, Lachowicz JE, Duffy RA.
Journal: Pharmacogenomics J. 4(6):394-402
- Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).
by Shah RR.
Journal: Br J Clin Pharmacol. 58(5):452-69
- Interethnic variability of ERCC2 polymorphisms.
by King CR, Yu J, Freimuth RR, McLeod HL, Marsh S.
Journal: Pharmacogenomics J. 11 2004;:
- Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management.
by Kajinami K, Takekoshi N, Brousseau ME, Schaefer EJ.
Journal: Atherosclerosis. 177(2):219-34
- The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development.
by Walker DK.
Journal: Br J Clin Pharmacol. 58(6):601-608
- Differential display polymerase chain reaction reveals increased expression of striatal rat glia-derived nexin following chronic clozapine treatment.
by Chong VZ, Costain W, Marriott J, Sindwani S, Knauer DJ, Wang JF, Young LT, Maccrimmon D, Mishra RK.
Journal: Pharmacogenomics J. 4(6):379-87
- Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections.
by Wunderink RG, Waterer GW.
Journal: Infect Dis Clin North Am. 18(4):743-59, vii
- Identification of a pharmacogenetic effect by linkage disequilibrium mapping.
by Xu CF, Lewis KF, Yeo AJ, McCarthy LC, Maguire MF, Anwar Z, Danoff TM, Roses AD, Purvis IJ.
Journal: Pharmacogenomics J. 4(6):374-8
- Race-based therapeutics.
by Bloche MG.
Journal: N Engl J Med. 351(20):2035-7
- CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians.
by Vasconcelos GM, Struchiner CJ, Suarez-Kurtz G.
Journal: Pharmacogenomics J. 11 2004;:
- Internet based clinical trial protocols -- as applied to a study of warfarin pharmacogenetics.
by Lindh JD, Kublickas M, Westgren M, Rane A.
Journal: Br J Clin Pharmacol. 58(5):482-7
- Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
by Murphy GM, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF.
Journal: Arch Gen Psychiatry. 61(11):1163-9
- Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors.
by García-Colunga J, Vázquez-Gómez E, Miledi R.
Journal: Pharmacogenomics J. 4(6):388-93
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|